{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T07:37:00Z","timestamp":1774251420368,"version":"3.50.1"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273288, 82403651, 82201491"],"award-info":[{"award-number":["82273288, 82403651, 82201491"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Bladder cancer is the tenth most common cancer worldwide and the sixth most common among men. However, research into representative tumor models for bladder cancer remains underdeveloped, limiting insights into tumor biology and drug development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We developed an integrated approach combining a novel gene expression mouse model (GEMM) with advanced organoid technology. This system was tracked longitudinally using single-cell sequencing to monitor tumor evolution and cellular dynamics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our model accurately recapitulates the single-cell molecular features and cellular communication networks observed in human bladder cancer. It provides a scalable and physiologically relevant platform for preclinical drug screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This integrated framework offers a new platform for studying tumor origin and evolution, overcoming key limitations of conventional systems and advancing bladder cancer research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1726443","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T06:43:03Z","timestamp":1774248183000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Rapid establishment of KRAS-driven bladder cancer initiation and immune escape models using genetically engineered mice and organoid approaches"],"prefix":"10.3389","volume":"17","author":[{"given":"Guoliang","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Urology Renji Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yishu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangzhengyi","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Urology Renji Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guojiang","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Urology Renji Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuqing","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HeJian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology Renji Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology Renji Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, School of Medicine, Shanghai Jiaotong University","place":["Shanghai, China"]},{"name":"Shanghai Key Laboratory for Cancer Systems Regulation and Clinical Translation (CSRCT)","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.82435","article-title":"Behind the smoke: A bladder cancer case report through the eyes of primary care","volume":"17","author":"Bento","year":"2025","journal-title":"Cureus"},{"key":"B2","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12935-024-03492-1","article-title":"GALNT6 promotes bladder cancer Malignancy and immune escape by epithelial-mesenchymal transition and CD8(+) T cells","volume":"24","author":"Sun","year":"2024","journal-title":"Cancer Cell Int"},{"key":"B3","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s12672-025-02297-6","article-title":"A single-cell atlas of bladder cancer unveils dynamic cellular composition and endothelial functional shifts during progression","volume":"16","author":"Song","year":"2025","journal-title":"Discov Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.5213\/inj.1632752.376","article-title":"Genetic and epigenetic alterations in bladder cancer","volume":"20","author":"Li","year":"2016","journal-title":"Int Neurourol J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2018.07.036","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"174","author":"Robertson","year":"2018","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102511","article-title":"Single-cell analyses of a novel mouse urothelial carcinoma model reveal a role of tumor-associated macrophages in response to anti-PD-1 therapy","volume":"14","author":"Xu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092275","article-title":"Molecular profiles of advanced urological cancers in the PERMED-01 precision medicine clinical trial","volume":"14","author":"Billon","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013821","article-title":"FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy","volume":"5","author":"Kompier","year":"2010","journal-title":"PloS One"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-017-0748-x","article-title":"Recent developments in the search for urinary biomarkers in bladder cancer","volume":"18","author":"Leiblich","year":"2017","journal-title":"Curr Urol Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000487882","article-title":"Genomic profiling of two histologically distinct rare urothelial cancers in a clinical setting to identify potential therapeutic options for treatment and management of disease","volume":"11","author":"Hesse","year":"2018","journal-title":"Case Rep Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-14-0030","article-title":"Modeling targeted inhibition of MEK and PI3 kinase in human pancreatic cancer","volume":"14","author":"Junttila","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15049","article-title":"Quadruple-editing of the MAPK and PI3K pathways effectively blocks the progression of KRAS-mutated colorectal cancer cells","volume":"112","author":"Wang","year":"2021","journal-title":"Cancer Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113508","article-title":"Reduced IQGAP2 promotes bladder cancer through regulation of MAPK\/ERK pathway and cytokines","volume":"23","author":"Song","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110893","article-title":"DUSP2 affects bladder cancer prognosis by down-regulating MEK\/ERK and P38 MAPK signaling pathways through PTPN7","volume":"112","author":"Zou","year":"2023","journal-title":"Cell Signal"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.62347\/XEBR7848","article-title":"Sotorasib inhibits ubiquitination degradation of TXNIP and suppresses glucose metabolism in KRAS(G12C) mutant bladder cancer","volume":"14","author":"Zhang","year":"2024","journal-title":"Am J Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14740338.2025.2499219","article-title":"Two first-generation KRAS inhibitor safety profiles: A disproportionality analysis of individual reports from the FDA adverse event reporting system","author":"Zhang","year":"2025","journal-title":"Expert Opin Drug Saf"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/cells11233868","article-title":"Translation potential and challenges of in vitro and murine models in cancer clinic","volume":"11","author":"Long","year":"2022","journal-title":"Cells"},{"key":"B18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrc3858","article-title":"Modelling bladder cancer in mice: Opportunities and challenges","volume":"15","author":"Kobayashi","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.008888","article-title":"Exploring molecular genetics of bladder cancer: Lessons learned from mouse models","volume":"5","author":"Ahmad","year":"2012","journal-title":"Dis Model Mech"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-0173","article-title":"Molecular subtype-specific immunocompetent models of high-grade urothelial carcinoma reveal differential neoantigen expression and response to immunotherapy","volume":"78","author":"Saito","year":"2018","journal-title":"Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1803595116","article-title":"Mouse and human urothelial cancer organoids: A tool for bladder cancer research","volume":"116","author":"Mullenders","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2017.19","article-title":"Patient-derived xenografts as in vivo models for research in urological Malignancies","volume":"14","author":"Inoue","year":"2017","journal-title":"Nat Rev Urol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"F1503","DOI":"10.1152\/ajprenal.00160.2019","article-title":"Stem cell antigen\/Ly6a protects against bladder fibrosis in mice","volume":"317","author":"Tassone","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41575-024-00965-6","article-title":"Fgfbp1(+) cells: Upper crypt intestinal epithelial regeneration","volume":"21","author":"Hindson","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B25","article-title":"From development to cancer - an ever-increasing role of AGR2","volume":"11","author":"Jach","year":"2021","journal-title":"Am J Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1038\/s41598-022-04980-y","article-title":"The significance of ErbB2\/3 in the conversion of induced pluripotent stem cells into cancer stem cells","volume":"12","author":"Hassan","year":"2022","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1011969","article-title":"Identification of a naturally-occurring canine model for early detection and intervention research in high grade urothelial carcinoma","volume":"12","author":"Dhawan","year":"2022","journal-title":"Front Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1132811","article-title":"Identification of IRAK1BP1 as a candidate prognostic factor in lung adenocarcinoma","volume":"13","author":"Guo","year":"2023","journal-title":"Front Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2167","article-title":"Rapid functional dissection of genetic networks via tissue-specific transduction and RNAi in mouse embryos","volume":"16","author":"Beronja","year":"2010","journal-title":"Nat Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13046-024-02979-z","article-title":"LATS1\/2 loss promote tumor immune evasion in endometrial cancer through downregulating MHC-I expression","volume":"43","author":"Yang","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/cas.16278","article-title":"Newly developed humanized anti-CKAP4 antibody suppresses pancreatic cancer growth by inhibiting DKK1-CKAP4 signaling","volume":"115","author":"Sada","year":"2024","journal-title":"Cancer Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8261","article-title":"Significance of TP53 mutation in bladder cancer disease progression and drug selection","volume":"7","author":"Wu","year":"2019","journal-title":"PeerJ"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101629","article-title":"Individualized prognosis stratification in muscle invasive bladder cancer: A pairwise TP53-derived transcriptome signature","volume":"29","author":"Liu","year":"2023","journal-title":"Transl Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1120329","article-title":"Syngeneic model of carcinogen-induced tumor mimics basal\/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer","volume":"13","author":"Shah","year":"2023","journal-title":"Front Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s10020-024-00835-6","article-title":"FK228 suppress the growth of human Malignant pleural mesothelioma tumor independent to epithelioid or non-epithelioid histology","volume":"30","author":"Chan","year":"2024","journal-title":"Mol Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00262-020-02653-1","article-title":"Romidepsin (FK228) regulates the expression of the immune checkpoint ligand PD-L1 and suppresses cellular immune functions in colon cancer","volume":"70","author":"Shi","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"B37","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","article-title":"Tumor evolution and drug response in patient-derived organoid models of bladder cancer","volume":"173","author":"Lee","year":"2018","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202414558","article-title":"Patient-derived bladder cancer organoids as a valuable tool for understanding tumor biology and developing personalized treatment","volume":"12","author":"Zhao","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189199","article-title":"Modeling bladder cancer in the laboratory: Insights from patient-derived organoids","volume":"1879","author":"Guo","year":"2024","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217793","article-title":"Patient-derived organoid co-culture systems as next-generation models for bladder cancer stem cell research","volume":"625","author":"Yang","year":"2025","journal-title":"Cancer Lett"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1726443\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T06:43:03Z","timestamp":1774248183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1726443\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2026.1726443"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1726443","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"article-number":"1726443"}}